Affiliate Zebra Aggregator Files to Sell 1M Shares of Zenas BioPharma
ZBIO has more than doubled off its 52-week low of $13.5 on elevated volume (3.3× avg).
Summary
Affiliate Zebra Aggregator, LP filed a Form 144 to sell 1 million shares of Zenas BioPharma, valued at approximately $31.9 million, with the sale expected on August 19, 2026.
Key Events · Ownership and Investor Activity · ZBIO
-
Affiliate Files to Sell 1M Shares
Zebra Aggregator, LP, an affiliate of Zenas BioPharma, filed a Form 144 to sell 1,000,000 shares of common stock.
-
Sale Valued at $31.9M
The proposed sale has an approximate market value of $31,910,000, based on the current share price.
-
Shares from Series B Financing
The shares were acquired on November 1, 2022, in a Series B financing transaction.
-
Sale Expected August 19, 2026
The sale is expected to occur on or about August 19, 2026, through broker J.P. Morgan Securities LLC.
Analysis · ZBIO · Life Sciences
An affiliate of Zenas BioPharma, Zebra Aggregator, LP, has filed a Form 144 to sell 1,000,000 shares with an approximate market value of $31.9 million. The shares were acquired in a Series B financing in November 2022. This is a significant sale by an affiliate, representing roughly 1.5% of the company's outstanding shares, and could create near-term selling pressure on the stock.
At the time of this filing, ZBIO was trading at $31.04 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2B. The 52-week trading range was $13.50 to $44.60. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.